LKYSF - Psilocybin and MDMA Get the Green Light for Medical Use in Canada
After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical purposes. Canada’s legislation now permits the use of psychedelics beyond palliative care, something health advocates are calling a major breakthrough in treating serious or life-threatening conditions. This news is great for patients interested in psychedelic treatments for mental illness and will likely offer companies Compass Pathways (NASDAQ:CMPS), ATAI Life Sciences (NASDAQ:ATAI), Revive Therapeutics Ltd. (OTC:RVVTF), Mind Medicine (MindMed) (NASDAQ:MNMD) (NEO:MMED), and Numinus Wellness (TSX:NUMI) (OTC:LKYSF) who are conducting clinical trials on various psychedelics a smoother pathway to ...
Get early insight on hidden secret gems on MicroSmallCap . Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here .
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer .
For further details see:
Psilocybin and MDMA Get the Green Light for Medical Use in Canada